GlassScriptPhysician profile
Shaun U Din
NPI 1932493152
$2,389.29
in general payments reported to CMS, 2019-2025
16 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $243 · 2021: $470 · 2022: $58.09 · 2023: $240 · 2024: $833 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071 · Travel and Lodging: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.79 |
| Travel and Lodging | $142.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $620.76 | 2019-2021 | |
| Reflexion Medical, INC. | $502.07 | 2024 | Reflexion Medical Radiotherapy System |
| Novocure INC. | $242.12 | 2021-2024 | Optune |
| Sumitomo Pharma America, INC. | $227.23 | 2023-2025 | Orgovyx |
| Siemens Medical Solutions USA, INC. | $147.01 | 2024 | Varian Ethos Treatment Planning |
| Celgene Corporation | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $119.64 | 2019-2023 | |
| Janssen Biotech, INC. | $110.37 | 2022-2025 | Erleada, Tecvayli, Akeega |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.91 | 2020 | |
| Myriad Genetic Laboratories, INC. | $54.03 | 2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $48.83 | 2024 | |
| Merck Sharp & Dohme LLC | $36.52 | 2021-2023 | Keytruda |
| Rigel Pharmaceuticals, INC. | $30.28 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.22 | 2020 | |
| Genzyme Corporation | $17.88 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Din listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.